Impower133: Updated overall survival (OS) analysis of first-line (1L) atezolizumab (ATEZO) plus carboplatin plus etoposide in extensive-stage SCLC (ES-SCLC)
Authors
Reck, MLiu, SV
Mansfield, AS
Mok, T
Scherpereel, A
Reinmuth, N
Garassino, MC
Carpeno
JD
Califano, Raffaele
Nishio, M
Orlandi, F
Alexander, JAA
Leal, T
Cheng, Y
Lee, JS
Lam, S
McCleland, M
Deng, Y
Phan, S
Horn, L
Affiliation
Lung Clinic Grosshansdorf, GrosshansdorfIssue Date
2020